moxisylyte has been researched along with Action Tremor in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mai, J | 1 |
| Olsen, RB | 1 |
| Abila, B | 1 |
| Wilson, JF | 1 |
| Marshall, RW | 1 |
| Richens, A | 1 |
2 other studies available for moxisylyte and Action Tremor
| Article | Year |
|---|---|
Depression of essential tremor by alpha-adrenergic blockade.
Topics: Humans; Moxisylyte; Parkinson Disease; Tremor | 1981 |
Differential effects of alpha-adrenoceptor blockade on essential, physiological and isoprenaline-induced tremor: evidence for a central origin of essential tremor.
Topics: Adult; Aged; Blood Pressure; Central Nervous System; Female; Heart Rate; Humans; Isoproterenol; Male | 1985 |